UNSPSC 51271622: Bupivacaine hydrochloride

This classification denotes an anesthetic agent with the molecular formula C18H28N2O.ClH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7TQO7W3VT8, chemically known as 2-piperidinecarboxamide, 1-butyl-n-(2,6-dimethylphenyl)- monohydrochloride, monohydrate but more generally known as bupivacaine hydrochloride, which bears US NIH Compound Identifier 64737. European Medicines Agency schedules Bupivacaine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00902MIG.

UNSPSC 51271622 Bupivacaine hydrochloride is a Commodity code for a local anesthetic pharmaceutical product that state and local governments procure primarily through multistate cooperative purchasing agreements serving healthcare facilities, correctional institutions, and emergency services. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, currently solicits generic multi-source pharmaceuticals and over-the-counter products under umbrella contracts that include bupivacaine and chemically similar local anesthetics as line items. State and local buyers access these products through authorized wholesale distributors rather than direct manufacturer contracts, with pricing transparency and compliance with FDA manufacturing standards and Drug Supply Chain Security Act (DSCSA) requirements as standard conditions. Vendors supplying under the code must maintain relationships with multiple authorized wholesalers, provide comprehensive product data including National Drug Codes (NDCs), strength, dosage form, and packaging configuration, and demonstrate pricing flexibility across multiple formats (flat price, net price, WAC-minus structures).

MMCAP's RFP for generic multi-source pharmaceuticals, posted January 20, 2026 with proposals due March 26, 2026, represents the primary current opportunity under this code. The solicitation draws vendors serving Minnesota and participating states including Oregon, with contract award and distributor onboarding targeted for May 15, 2026 and effective July 1, 2026. The RFP emphasizes price competitiveness (weighted at 75 percent of evaluation), administrative fee compliance (5 percent), EDI capability (5 percent), and pricing format flexibility. Vendors must carry professional liability of $2 million, commercial general liability of $5 million per occurrence, and network security and privacy liability of $2 million, and agree to a 3 percent administrative fee on all contract purchases with performance penalties for reporting delays or onboarding failures. The contract term runs two years for new responders with optional extensions, or through June 30, 2028 for incumbent vendors.